PCVX Vaxcyte, Inc.
$60.87▲ +1.50%
Healthcare
Other
Volume 570.1K
Avg Volume (10D) 2.39M
Key Metrics & Fundamentals
Market Cap
$9.58B
P/E Ratio
–
Div Yield
0.00%
52W Range
39.87 - 90.75
% vs 50 MA
-2.59%
% vs 200 MA
5.70%
RSI-14
44.6
MACD Histogram
-0.8600
Beta (1Y vs SPY)
1.08
Free Cash Flow
-$237.05M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$296.85M
COGS
–
Operating Exp
$302.78M
Operating Income
-$302.78M
EBIT
-$302.78M
Pretax Income
-$284.30M
Net Income
-$284.30M
EPS (Diluted)
-1.97
Price & Volume History
Loading chart…
Recent News
Wall Street Analysts Think Vaxcyte (PCVX) Could Surge 75.6%: Read This Before Placing a Bet
Zacks · Oct 14, 2026 8:55 AM ET
BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push
Stocktwits · Oct 9, 2026 8:09 PM ET
Vaxcyte Closes Offerings of Common Stock, Warrants, and Senior Notes
MT Newswires · Oct 9, 2026 4:27 PM ET
Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Convertible Senior Notes
GlobeNewswire · Oct 9, 2026 4:05 PM ET
Sector Update: Healthcare
MT Newswires · Oct 9, 2026 1:18 PM ET
Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines
MT Newswires · Oct 9, 2026 10:57 AM ET
Why Vaxcyte (PCVX) Is Getting Attention Again
Simply Wall St. · Oct 8, 2026 2:15 PM ET
Vaxcyte Prices $1 Billion Offerings of Stock, Prefunded Warrants, 2032 Notes
MT Newswires · Oct 7, 2026 4:08 AM ET
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
GlobeNewswire · Oct 6, 2026 10:48 PM ET
Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers
Investor's Business Daily · Oct 6, 2026 4:34 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PCVX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.